These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16400314)

  • 61. Relapsing inflammatory optic neuritis: is it neuromyelitis optica?
    de Seze J; Arndt C; Jeanjean L; Zephir H; Blanc F; Labauge P; Bouyon M; Ballonzoli L; Fleury M; Vermersch P; Speeg C
    Neurology; 2008 May; 70(22):2075-6. PubMed ID: 18505981
    [No Abstract]   [Full Text] [Related]  

  • 62. Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy.
    Vermersch P; Kappos L; Gold R; Foley JF; Olsson T; Cadavid D; Bozic C; Richman S
    Neurology; 2011 May; 76(20):1697-704. PubMed ID: 21576685
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Multiple sclerosis.
    Hawker K; Frohman E
    Prim Care; 2004 Mar; 31(1):201-26. PubMed ID: 15110166
    [No Abstract]   [Full Text] [Related]  

  • 64. [Therapy of multiple sclerosis].
    Simó M
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [110th Scientific Meeting of the Japanese Society of Internal Medicine: Educational lecture: 11. Multiple sclerosis (MS) and neuromyelitis optica (NMO)].
    Fujihara K
    Nihon Naika Gakkai Zasshi; 2013 Sep; 102(9):2426-32. PubMed ID: 24228437
    [No Abstract]   [Full Text] [Related]  

  • 66. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.
    Langer-Gould A; Atlas SW; Green AJ; Bollen AW; Pelletier D
    N Engl J Med; 2005 Jul; 353(4):375-81. PubMed ID: 15947078
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.
    Schwab N; Schneider-Hohendorf T; Wiendl H
    Int Immunol; 2015 Jan; 27(1):47-53. PubMed ID: 25326459
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Interferon beta-1b in multiple sclerosis--news regarding open questions].
    Nervenarzt; 1997 Aug; 68(8 Suppl Interferon):1-4. PubMed ID: 9380220
    [No Abstract]   [Full Text] [Related]  

  • 69. [Natalizumab in multiple sclerosis].
    Rajda C; Bencsik K; Vécsei L;
    Ideggyogy Sz; 2008 May; 61(5-6):204-8. PubMed ID: 18567397
    [No Abstract]   [Full Text] [Related]  

  • 70. [Progressive multifocal leukoencephalopathy and natalizumab-related immune reconstitution inflammatory syndrome: the advantage of MRI].
    Gibelin N; Daelman L; Goulipian S; Wynckel A; Chaunu MP; Tourbah A
    Rev Neurol (Paris); 2014 Jan; 170(1):48-50. PubMed ID: 24139244
    [No Abstract]   [Full Text] [Related]  

  • 71. [Report of the 55th meeting of the American Academy of Neurology. Honolulu, March 29-April 6, 2003].
    Becker H; Chochon F; de Toffol B; Defebvre L; Léger JM; Pierrot-Deseilligny C; Sellal F
    Rev Neurol (Paris); 2003 Apr; 159(4):470-86. PubMed ID: 12795263
    [No Abstract]   [Full Text] [Related]  

  • 72. Central nervous system white matter diseases other than multiple sclerosis.
    O'Riordan JI
    Curr Opin Neurol; 1997 Jun; 10(3):211-4. PubMed ID: 9229127
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Natalizumab-associated reversible encephalopathy syndrome mimicking progressive multifocal leukoencephalopathy.
    Décard BF; Haghikia A; Tönnes C; Thöne J; Lukas C; Chan A; Gold R
    Mult Scler; 2013 Feb; 19(2):249-51. PubMed ID: 22596228
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
    Ko MY; Stefoski D; Balabanov R
    Neurology; 2011 Sep; 77(10):1020; author reply 1020. PubMed ID: 21893676
    [No Abstract]   [Full Text] [Related]  

  • 75. An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis.
    Vollmer TL; Phillips JT; Goodman AD; Agius MA; Libonati MA; Giacchino JL; Grundy JS
    Mult Scler; 2004 Oct; 10(5):511-20. PubMed ID: 15471366
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Devic's neuromyelitis optica: clinical and imaging findings.
    Vandevyver V; Lemmerling M; De Potter R; Verstraete K
    JBR-BTR; 2007; 90(4):284-7. PubMed ID: 17966247
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Natalizumab and progressive multifocal leukoencephalopathy: migrating towards safe adhesion molecule therapy in multiple sclerosis.
    Bennett JL
    Neurol Res; 2006 Apr; 28(3):291-8. PubMed ID: 16687056
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Progressive multifocal leukoencephalopathy as a complication of natalizumab therapy].
    Soilu-Hänninen M; Päivärinta M; Sonninen P; Parkkola R; Vuorinen T; Erälinna JP
    Duodecim; 2013; 129(7):765-70. PubMed ID: 23720945
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Treatment of progressive multifocal leukoencephalopathy associated with natalizumab.
    Wenning W; Haghikia A; Laubenberger J; Clifford DB; Behrens PF; Chan A; Gold R
    N Engl J Med; 2009 Sep; 361(11):1075-80. PubMed ID: 19741228
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Blocking adhesion molecules with natalizumab in multiple sclerosis].
    Schreiner B; Kieseier BC; Hartung HP; Hohlfeld R; Wiendl H
    Nervenarzt; 2005 Aug; 76(8):999-1005. PubMed ID: 15812675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.